학술논문

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
Document Type
Journal
Source
ANNALS OF ONCOLOGY; MAY 2022, 33 pS127-pS127, 1p. Supplement: 3
Subject
Language
English
ISSN
15698041